Published in Br J Haematol on October 01, 1979
Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in alpha- and beta-thalassemia. J Exp Med (1991) 1.27
Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest (1986) 1.15
Ineffective erythropoiesis in β -thalassemia. ScientificWorldJournal (2013) 1.01
Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence. J Membr Biol (2009) 0.83
Selective erythroid replacement in murine beta-thalassemia using fetal hematopoietic stem cells. Proc Natl Acad Sci U S A (1993) 0.77
Use of cationized ferritin as a label of negative charges on cell surfaces. J Ultrastruct Res (1972) 5.78
The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem (1975) 4.15
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Major glycoprotein of the human erythrocyte membrane: evidence for an amphipathic molecular structure. Arch Biochem Biophys (1973) 2.44
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol (1978) 2.07
The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci (1974) 1.99
Adherence of Mycoplasma gallisepticum to human erythrocytes. Infect Immun (1978) 1.98
Redistribution of surface anionic sites on the luminal front of blood vessel endothelium after interaction with polycationic ligand. J Cell Biol (1976) 1.88
Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils. Science (1979) 1.84
Proliferation and maturation of human erythroid progenitors in liquid culture. Blood (1989) 1.78
Immunological analysis of Mycoplasma membranes. J Bacteriol (1969) 1.66
Surface charge properties of the luminal front of blood vessel walls: an electron microscopical analysis. Thromb Res (1975) 1.60
The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem (1971) 1.57
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. QJM (2008) 1.56
Attachment of mycoplasmas to erythrocytes: a model to study mycoplasma attachment to the epithelium of the host respiratory tract. Isr J Med Sci (1981) 1.56
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med (1993) 1.51
Synthesis and turnover of membrane protein and lipid in Mycoplasma laidlawii. Biochim Biophys Acta (1969) 1.50
Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril (1998) 1.46
Sonographic estimation of fetal head circumference: how accurate are we? Ultrasound Obstet Gynecol (2011) 1.42
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
Activated oxygen and haemolysis. Br J Haematol (1975) 1.41
Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. J Biol Chem (1971) 1.38
Electron-microscope studies of the red cell in paroxysmal nocturnal haemoglobinuria. Br J Haematol (1965) 1.36
Isolation of binding sites to glycophorin from Mycoplasma pneumoniae membranes. Infect Immun (1980) 1.35
Studies on the major sialoglycoprotein of the human red cell membrane. Isolation and characterization of tryptic glycopeptides. Biochemistry (1973) 1.35
An electron microscopic study of nuclear elimination from the late erythroblast. J Cell Biol (1967) 1.32
Electron microscopic study of penetration of Newcastle disease virus into cells leading to formation of polykaryocytes. J Cell Sci (1967) 1.32
Sialic acid residues mediate Mycoplasma pneumoniae attachment to human and sheep erythrocytes. Infect Immun (1982) 1.31
Adherence of erythrocytes to Mycoplasma pneumoniae. Infect Immun (1979) 1.29
Cholesterol-phosphatidylcholine dispersions as donors of cholesterol to Mycoplasma membranes. Biochim Biophys Acta (1977) 1.29
Multiphasic interactions of Mycoplasma pulmonis with erythrocytes defined by adherence and hemagglutination. Infect Immun (1984) 1.28
Detection of the major adhesin P1 in triton shells of virulent Mycoplasma pneumoniae. Infect Immun (1985) 1.26
Cardiopulmonary assessment in beta-thalassemia major. Chest (1990) 1.26
Promotion of wound repair in mice by application of glucan. J Reticuloendothel Soc (1980) 1.24
Oxidative denaturation of red blood cells in thalassemia. Semin Hematol (1990) 1.24
Characterization of the mycoplasma membrane proteins. II. Solubilization and enzymic activities of Acholeplasma laidlawii membrane proteins. Biochim Biophys Acta (1971) 1.23
A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor. Proc Natl Acad Sci U S A (1980) 1.23
Distinguishing between Mn-containing and Fe-containing superoxide dismutases in crude extracts of cells. Arch Biochem Biophys (1980) 1.22
Inhibition of host cell catalase by Mycoplasma pneumoniae: a possible mechanism for cell injury. Infect Immun (1983) 1.22
Molecular features of the major glycoprotein of the human erythrocyte membrane. Fed Proc (1973) 1.20
Lipid membrane peroxidation in beta-thalassemia major. Blood (1976) 1.18
Denaturation of the normal and abnormal hemoglobin molecule. Semin Hematol (1974) 1.17
Adherence of Mycoplasma gallisepticum to glass. J Gen Microbiol (1979) 1.16
Comparative study of nuclear expulsion from the late erythroblast and cytokinesis. Exp Cell Res (1970) 1.15
Purification and properties of acetate kinase from Acholeplasma laidlawii. J Bacteriol (1979) 1.14
Detection of Mycoplasma pneumoniae adhesin (P1) in the nonhemadsorbing population of virulent Mycoplasma pneumoniae. Infect Immun (1985) 1.13
Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease. Nature (1969) 1.12
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant (2001) 1.11
Characterization of the mycoplasma membrane proteins. VI. Composition and disposition of proteins in membranes from aging Mycoplasma hominis cultures. Biochim Biophys Acta (1976) 1.11
Ontogenic development of the reactivity of macrophages to antigenic stimulation. Cell Immunol (1973) 1.10
Role of superoxide anion in host cell injury induced by mycoplasma pneumoniae infection. A study in normal and trisomy 21 cells. J Clin Invest (1984) 1.10
Characterization of the myoplasma membrane proteins. 3. Gel filtration and immunological characterization of Acholeplasma laidlawii membrane proteins. Biochim Biophys Acta (1972) 1.10
Distribution of surface charge and concanavalin A-binding sites on normal and malignant transformed cells. Exp Cell Res (1974) 1.09
Serum lipoproteins as cholesterol donors to mycoplasma membranes. Biochem Biophys Res Commun (1976) 1.09
Binding of plant lectins to mycoplasma cells and membranes. J Bacteriol (1976) 1.09
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
In vitro recognition of "old" red blood cells by macrophages from syngeneic mice: characteristics of the macrophage-red blood cell interaction. J Reticuloendothel Soc (1980) 1.06
beta 0-Thalassemia complicated by autoimmune hemolytic anemia. Globin synthesis during immunosuppressive therapy. Acta Haematol (1980) 1.06
Isolation of membrane glycoproteins by affinity chromatography in the presence of detergents. Biochim Biophys Acta (1976) 1.06
Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr J Med Sci (1972) 1.05
Divalent cations in native and reaggregated mycoplasma membranes. J Bacteriol (1973) 1.05
Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci (1970) 1.05
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol (1986) 1.05
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) (1978) 1.04
Isolation of a glycoprotein from Mycoplasma pneumoniae membranes. Infect Immun (1977) 1.04
Endothelial surface charge and its possible relationship to thrombogenesis. Ann N Y Acad Sci (1976) 1.04
Enzyme activities in human red blood cells of different age groups. Isr J Med Sci (1967) 1.03
Endocytosis and exocytosis in membrane remodelling during reticulocyte maturation. Br J Haematol (1974) 1.02
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02
A new polymorphism in the human beta-globin gene useful in antenatal diagnosis. J Clin Invest (1981) 1.02
Agglutination by polylysine of young and old red blood cells. Biochim Biophys Acta (1966) 1.02
Reduction in surface charge as an explanation of the recognition by macrophages of nuclei expelled from normoblasts. J Cell Biol (1969) 1.01
Erythropoietin triggers a burst of GATA-1 in normal human erythroid cells differentiating in tissue culture. Nucleic Acids Res (1993) 1.00
Adherence of mycoplasmas to cells and inert surfaces: phenomena, experimental models and possible mechanisms. Isr J Med Sci (1981) 1.00
Absence of beta mRNA in beta0-thalassemia in Kurdish Jews. Blood (1978) 1.00
Novel treatment options in the severe beta-globin disorders. Br J Haematol (1995) 0.99
Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood (1987) 0.99
The demonstration of ferrihemochrome intermediates in heinz body formation following the reduction of oxyhemoglobin A by acetylphenylhydrazone. Biochim Biophys Acta (1975) 0.99
Blood group phenotypes and hemoglobin S. An anthropologic study in two Israeli Arab communities. Acta Haematol (1976) 0.98
Treatment of human ulcers by application of macrophages prepared from a blood unit. Exp Gerontol (1998) 0.98
Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with beta-thalassemia (major and intermedia). J Lab Clin Med (1976) 0.98
Toward anti-adhesion therapy for microbial diseases. Trends Microbiol (1996) 0.98
Mean corpuscular volume of heterozygotes for beta-thalassemia correlates with the severity of mutations. Blood (1992) 0.98
Wound repair in mice as influenced by age and antimacrophage serum. J Gerontol (1987) 0.97
Carbohydrate content and enzymic activites in the membrane of Spiroplasma citri. J Gen Microbiol (1977) 0.97
The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells (1993) 0.97
Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. Proc Natl Acad Sci U S A (1979) 0.96
Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol (1993) 0.96
Juvenile leg ulceration in beta-thalassemia major and intermedia. Plast Reconstr Surg (1982) 0.96
In vitro studies on the mechanism of adherence and pathogenicity of mycoplasmas. Isr J Med Sci (1984) 0.95
Protective effects of the glutathione redox cycle and vitamin E on cultured fibroblasts infected by Mycoplasma pneumoniae. Infect Immun (1986) 0.95
Blood group phenotypes and the origin of sickle cell hemoglobin in Sicilians. Acta Haematol (1978) 0.94
Red cell membrane glycophorin labeling from within the lipid bilayer. Science (1978) 0.94
Visceral leishmaniasis: a difficult diagnosis and unusual causative agent. J Infect Dis (1991) 0.94
Influence of cell shape and surface charge on attachment of Mycoplasma pneumoniae to glass surfaces. J Bacteriol (1983) 0.94